UNITED BIOMEDICAL INC - 25 Apr 2022 Form 4 Insider Report for Vaxxinity, Inc.

Role
10%+ Owner
Signature
/s/ Mei Mei Hu, As Director and Officer
Issuer symbol
VAXX on OTC
Transactions as of
25 Apr 2022
Net transactions value
+$27,073
Form type
4
Filing time
27 Apr 2022, 20:36:18 UTC
Previous filing
15 Nov 2021
Next filing
28 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VAXX Class A common stock Purchase $27,073 +8,038 +0.16% $3.37 5,193,454 25 Apr 2022 Direct F1, F2
holding VAXX Class A common stock 4,212,495 25 Apr 2022 Held by United Biomedical Inc., Asia F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2 The price reported is a weighted average price.
F3 Held by United Biomedical, Asia Inc. ("UBIA"). The Reporting Person, through a subsidiary, holds a majority equity interest in UBIA and may be deemed to be the beneficial owner of the shares held by UBIA. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by UBIA in which the Reporting Person has no pecuniary interest.